Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer's Detection ...
Algernon Pharmaceuticals ( ($TSE:AGN) ) just unveiled an announcement. Algernon Pharmaceuticals has announced a CAD $4 million non-dilutive ...
Preparing for a PET scan requires switching to a no-sugar diet the day before the scan. People with diabetes may have special instructions regarding medications. Doctors typically schedule PET scans ...
Researchers from Alliance Medical Ltd. performed a retrospective case series review of oncologic FDG PET-CT scans in patients taking GLP-1 agonists. They observed several atypical patterns of tracer ...
Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by conventional imaging. Among patients with high-risk nonmetastatic ...
New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...
Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it has signed a definitive equipment order and ...
Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results